20th Sep 2006 07:03
Advanced Medical Solutions Grp PLC20 September 2006 For immediate release 20 September 2006 Advanced Medical Solutions Group plc ("AMS" or "the Company") Science and Innovation Minister Lord Sainsbury is Guest of Honour at opening of new manufacturing line Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the globalwoundcare technology company, hosted a visit from Lord Sainsbury, the Scienceand Innovation Minister, who was guest of honour at the official opening of anew manufacturing line for hydrocolloid wound dressings on Tuesday 19 Septemberat its Cheshire manufacturing and R&D facility. AMS is a leading provider of advanced woundcare products to the global market.New technologies are taken to market via major branded partners who have theability to provide the necessary marketing and promotional support tocommercialise these products worldwide. AMS is also well placed to address thegrowing trend towards private label products in advanced woundcare throughprovision of own-label ranges to distribution partners. The Company sells direct into the NHS and seeks to deliver innovation throughits branded partners and cost saving initiatives through its ActivHeal(R) valuerange. The ActivHeal(R) range offers equivalent performance to branded versionsbut at a significantly reduced cost, thus delivering real and immediate savingsto the NHS estimated at £25 million per year. The hydrocolloid product is a key part of the ActivHeal(R) range and the newmanufacturing line has been introduced to offer increased capacity to the NHSfor this particular product. AMS has made a £100,000 investment in upgradingmanufacturing equipment and clean room facilities to support future growth. Lord Sainsbury's visit was hosted by Dr. Don Evans, CEO, who introduced him tomanagement and staff whilst undertaking a tour of the Company's premises andofficially opening the new manufacturing line. Science and Innovation Minister Lord Sainsbury said: "I was delighted to be able to join the management team and members of staff atthe official opening of the company's new facilities, which include a new cleanroom and upgraded manufacturing equipment to increase production capacity andproductivity at the factory. "The global woundcare market is estimated to be worth $13 billion and it ispleasing to see investments in Research and Development and capital equipment bycompanies such as AMS resulting in real economic growth which supports theGovernment's drive to build and sustain world leading knowledge based companies. "I wish Advanced Medical Solutions Group every success for the future and hopethe company continues to go from strength to strength." Commenting on this visit, Dr. Don Evans, Chief Executive of AMS, stated: "We are delighted that Lord Sainsbury was able to visit our R&D laboratories andmanufacturing facilities at Winsford. As a UK based technology company, AMS isideally placed to become a new generation woundcare supplier to the NHS andglobal markets through a balance of innovation and cost management. This newinvestment supports this strategy." - ENDS - For further information, please contact: Advanced Medical Solutions Group plc Tel : +44 (0) 1606 545508Don Evans, Chief ExecutiveMary Tavener, Finance Directorwww.admedsol.com Buchanan Communications Tel: +44 (0) 20 7466 5000Mark Court, Mary-Jane Johnson Notes to Editors: Advanced Medical Solutions is a leading company in the development andmanufacture of products for the $13 billion global woundcare market. Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions isfocused on the design, development and manufacture of innovative andtechnologically advanced products for woundcare and other medical applications. In-house natural and synthetic polymer technology is used to provide advancedwound dressings based on the moist healing principle. AMS' resources ensure aunique position as a vertically integrated 'one stop shop' to provide allcategories of moist wound healing products. The Company has the capability tomove from product design and development through to production and deliveryready for distribution into customer markets. The acquisition of MedLogic in 2002 has brought AMS products and technology incyanoacrylate based tissue adhesives that offer benefits over sutures andstaples for closing wounds sold direct to hospitals or through distributors. AMS' technology and products currently serve the majority of the key globalmarkets and strategic partners. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Advanced Medical Solutions Group